MEKERK signaling is a therapeutic target in metastatic castration resistant prostate cancer
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer
10:55 EST 25 Feb 2019 |
NEJM
More From BioPortfolio on "MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer"